Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection
Authors:
Open Access
- 28 May 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Abstract
Integrase strand transfer inhibitors (INSTI) are a main component of the current antiretroviral regimens recommended for treatment of HIV infection. However, little is known about the impact of INSTI on neurocognition and neuroimaging. We developed a prospective observational trial to evaluate the effects of INSTI-based antiretroviral therapy on comprehensive brain outcomes (cognitive, functional, and imaging) according to the time since HIV-1 acquisition. We recruited men living with HIV who initiated antiretroviral therapy with INSTI < 3 months since the estimated date of HIV-1 acquisition (n = 12) and > 6 months since estimated date of HIV-1 acquisition (n = 15). We also recruited a group of matched seronegative individuals (n = 15). Assessments were performed at baseline (before initiation of therapy in HIV arms) and at weeks 4 and 48. Baseline cognitive functioning was comparable between the arms. At week 48, we did not find cognitive differences between starting therapy with INSTI earlier than 3 months or later than 6 months after acquisition of HIV-1 infection. Functional status was poorer in individuals diagnosed earlier. This effect recovered 48 weeks after initiation of therapy. Regarding brain imaging, we found that men living with HIV initiating antiretroviral therapy later experienced a greater decrease in medial orbitofrontal cortex over time, with expected negative repercussions for decision-making tasks.Keywords
Funding Information
- Instituto de Salud Carlos III (FI17/00294, FI17/00294)
- Ministerio de Economía y Competitividad (MTM2015-64465-C2-1-R (MINECO/FEDER))
- Generalitat de Catalunya (2017 SGR 622 (GRBIO))
This publication has 40 references indexed in Scilit:
- HIV and Neurocognitive DysfunctionCurrent HIV/AIDS Reports, 2013
- Symmetric diffeomorphic modeling of longitudinal structural MRIFrontiers in Neuroscience, 2013
- Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV InfectionPLOS ONE, 2012
- The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?BMC Infectious Diseases, 2011
- Subcortical brain atrophy persists even in HAART-regulated HIV diseaseBrain Imaging and Behavior, 2011
- Neurocognitive functioning in acute or early HIV infectionJournal of NeuroVirology, 2010
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- The impact of HIV-associated neuropsychological impairment on everyday functioningJournal of the International Neuropsychological Society, 2004
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983